SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-070613
Filing Date
2024-06-07
Accepted
2024-06-07 16:07:12
Documents
1
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5930
  Complete submission text file 0000950170-24-070613.txt   7493
Mailing Address C/O TETRAPHASE PHARMACEUTICALS, INC. 480 ARSENAL ST., SUITE 101 WATERTOWN MA 02472
Business Address
Chodakewitz Jeffrey (Reporting) CIK: 0001610876 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38359 | Film No.: 241029373

Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)